Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mical Paul

Showing results (11-20 of 342) with videos related to

Pageof 35
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2013
Editorial commentary: combination therapy for Pseudomonas aeruginosa bacteremia: where do we stand?Mical Paul, Leonard Leibovici
The Journal of Antimicrobial Chemotherapy|May 11, 2013
A breach in patients' safety in randomized controlled trials of antibiotic drugsLeonard Leibovici, Mical Paul
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 5, 2024
Seeing is BelievingErlangga Yusuf, Mical Paul
The Lancet. Infectious Diseases|March 29, 2005
Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemiaMical Paul, Leonard Leibovici
The Lancet. Respiratory Medicine|January 15, 2016
Antibiotic treatment: balancing patients' rightsLeonard Leibovici, Mical Paul
The Journal of Antimicrobial Chemotherapy|April 8, 2006
Comment on guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UKLeonard Leibovici, Mical Paul
Mayo Clinic Proceedings|September 24, 2005
Systematic reviews and meta-analysis of febrile neutropeniaMical Paul, Leonard Leibovici
The Journal of Infectious Diseases|December 15, 2017
Drug Development for Multidrug-Resistant Bacteria: Why Compromise?Mical Paul, Leonard Leibovici
Infectious Disease Clinics of North America|April 28, 2009
Combination antimicrobial treatment versus monotherapy: the contribution of meta-analysesMical Paul, Leonard Leibovici
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 13, 2025
Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam versus carbapenem treatment: a propensity-matched cohort studyHagar Dallasheh, Mical Paul
Pageof 35

Showing results (11-20 of 342) with videos related to

Sort By:
Pageof 35
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2013
Editorial commentary: combination therapy for Pseudomonas aeruginosa bacteremia: where do we stand?Mical Paul, Leonard Leibovici
The Journal of Antimicrobial Chemotherapy|May 11, 2013
A breach in patients' safety in randomized controlled trials of antibiotic drugsLeonard Leibovici, Mical Paul
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 5, 2024
Seeing is BelievingErlangga Yusuf, Mical Paul
The Lancet. Infectious Diseases|March 29, 2005
Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemiaMical Paul, Leonard Leibovici
The Lancet. Respiratory Medicine|January 15, 2016
Antibiotic treatment: balancing patients' rightsLeonard Leibovici, Mical Paul
The Journal of Antimicrobial Chemotherapy|April 8, 2006
Comment on guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UKLeonard Leibovici, Mical Paul
Mayo Clinic Proceedings|September 24, 2005
Systematic reviews and meta-analysis of febrile neutropeniaMical Paul, Leonard Leibovici
The Journal of Infectious Diseases|December 15, 2017
Drug Development for Multidrug-Resistant Bacteria: Why Compromise?Mical Paul, Leonard Leibovici
Infectious Disease Clinics of North America|April 28, 2009
Combination antimicrobial treatment versus monotherapy: the contribution of meta-analysesMical Paul, Leonard Leibovici
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 13, 2025
Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam versus carbapenem treatment: a propensity-matched cohort studyHagar Dallasheh, Mical Paul
Pageof 35